ZA887771B - Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes - Google Patents

Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes

Info

Publication number
ZA887771B
ZA887771B ZA887771A ZA887771A ZA887771B ZA 887771 B ZA887771 B ZA 887771B ZA 887771 A ZA887771 A ZA 887771A ZA 887771 A ZA887771 A ZA 887771A ZA 887771 B ZA887771 B ZA 887771B
Authority
ZA
South Africa
Prior art keywords
lfa
lymphocytes
antigen
human
monoclonal antibody
Prior art date
Application number
ZA887771A
Other languages
English (en)
Inventor
Stuart F Schlossman
F Schlossman Stuart
Chikao Morimoto
Morimoto Chikao
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of ZA887771B publication Critical patent/ZA887771B/xx

Links

Classifications

    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03G—ELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G15/00—Apparatus for electrographic processes using a charge pattern
    • G03G15/65—Apparatus which relate to the handling of copy material
    • G03G15/6517—Apparatus for continuous web copy material of plain paper, e.g. supply rolls; Roll holders therefor
    • G03G15/6526—Computer form folded [CFF] continuous web, e.g. having sprocket holes or perforations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03G—ELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G15/00—Apparatus for electrographic processes using a charge pattern
    • G03G15/14—Apparatus for electrographic processes using a charge pattern for transferring a pattern to a second base
    • G03G15/16—Apparatus for electrographic processes using a charge pattern for transferring a pattern to a second base of a toner pattern, e.g. a powder pattern, e.g. magnetic transfer
    • G03G15/1695—Apparatus for electrographic processes using a charge pattern for transferring a pattern to a second base of a toner pattern, e.g. a powder pattern, e.g. magnetic transfer with means for preconditioning the paper base before the transfer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03G—ELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G2215/00—Apparatus for electrophotographic processes
    • G03G2215/00362—Apparatus for electrophotographic processes relating to the copy medium handling
    • G03G2215/00367—The feeding path segment where particular handling of the copy medium occurs, segments being adjacent and non-overlapping. Each segment is identified by the most downstream point in the segment, so that for instance the segment labelled "Fixing device" is referring to the path between the "Transfer device" and the "Fixing device"
    • G03G2215/00409—Transfer device
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03G—ELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G2215/00—Apparatus for electrophotographic processes
    • G03G2215/00362—Apparatus for electrophotographic processes relating to the copy medium handling
    • G03G2215/00443—Copy medium
    • G03G2215/00451—Paper
    • G03G2215/00455—Continuous web, i.e. roll
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03G—ELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G2215/00—Apparatus for electrophotographic processes
    • G03G2215/00362—Apparatus for electrophotographic processes relating to the copy medium handling
    • G03G2215/00443—Copy medium
    • G03G2215/00451—Paper
    • G03G2215/00455—Continuous web, i.e. roll
    • G03G2215/00459—Fan fold, e.g. CFF, normally perforated
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03G—ELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G2215/00—Apparatus for electrophotographic processes
    • G03G2215/00362—Apparatus for electrophotographic processes relating to the copy medium handling
    • G03G2215/00535—Stable handling of copy medium
    • G03G2215/00607—Debris handling means
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA887771A 1987-11-02 1988-10-18 Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes ZA887771B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/116,514 US5002869A (en) 1987-11-02 1987-11-02 Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes

Publications (1)

Publication Number Publication Date
ZA887771B true ZA887771B (en) 1990-06-27

Family

ID=22367627

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA887771A ZA887771B (en) 1987-11-02 1988-10-18 Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes

Country Status (13)

Country Link
US (1) US5002869A (fr)
EP (1) EP0387286B1 (fr)
JP (1) JP3158119B2 (fr)
CN (1) CN1033074A (fr)
AR (1) AR240175A1 (fr)
AU (1) AU618563B2 (fr)
CA (1) CA1305928C (fr)
DE (1) DE3855201T2 (fr)
ES (1) ES2017806A6 (fr)
IE (1) IE62056B1 (fr)
IL (1) IL88160A0 (fr)
WO (1) WO1989004175A1 (fr)
ZA (1) ZA887771B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645016B2 (en) * 1989-06-02 1994-01-06 Johns Hopkins University School Of Medicine, The Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore
US5100378A (en) * 1989-06-09 1992-03-31 Neorx Corporation Enhancement of target cell localization of lymphoid cells
NZ236792A (en) * 1990-01-19 1993-05-26 Merck & Co Inc Recombinant human anti-cd18 antibody, murine 1b4 heavy or light chain variable region, dna, vectors, mammalian host and pharmaceutical compositions
US5273738A (en) * 1990-03-03 1993-12-28 Fred Hutchinson Cancer Research Center Radiation delivery to lymphoid and marrow tissues
US5277892A (en) * 1990-08-08 1994-01-11 Rhomed Incorporated In vivo lymphocyte tagging
US5223241A (en) * 1990-10-01 1993-06-29 The General Hospital Corporation Method for early detection of allograft rejection
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
JPH08500826A (ja) * 1992-08-21 1996-01-30 ジェネンテク，インコーポレイテッド Ｌｆａ−１仲介疾患を処置する方法
FR2700471B1 (fr) * 1993-01-21 1995-04-07 Pasteur Merieux Serums Vacc Utilisation d'anticorps monoclonaux anti-LFA-1 pour la préparation d'un médicament destiné à prévenir le rejet des greffes d'organes solides et médicaments obtenus.
US6534057B2 (en) 1993-03-19 2003-03-18 Allen D. Allen Method increasing the delayed-type hypersensitivity response by infusing LFA-1-specific antibodies
US5651970A (en) * 1993-03-19 1997-07-29 Allen; Allen D. Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics
AU684074B2 (en) * 1993-03-19 1997-12-04 Allen D. Allen Methods for inhibiting HIV associated disease using monoclonal antibodies directed against anti-self cytotoxic T-cells
AU6256796A (en) * 1995-06-06 1996-12-24 D. Allen Allen Method for treating molluscum contagiosum resulting from hiv infection
US6001356A (en) * 1995-09-29 1999-12-14 Rush-Presbyterian-St. Luke's Medical Center Method of inhibiting tissue destruction in autoimmune disease using anti-CD44 antibodies
US20020081294A1 (en) * 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
US5914112A (en) * 1996-01-23 1999-06-22 Genentech, Inc. Anti-CD18 antibodies in stroke
US6582698B1 (en) 1999-03-19 2003-06-24 Genentech, Inc. Treatment method
IL145480A0 (en) 1999-03-19 2002-06-30 Genentech Inc Treatment of lfa-1 associated disorders with increasing doses of lfa-1
US6919077B2 (en) * 2002-09-27 2005-07-19 Aids Research, Llc LFA-1 alpha subunit antibodies and methods of use
AU2005244751A1 (en) * 2004-04-16 2005-12-01 Genentech, Inc. Method for augmenting B cell depletion
JP2008507592A (ja) * 2004-06-09 2008-03-13 ジェネンテック・インコーポレーテッド 環状肉芽腫又はサルコイドの治療法
US7789282B2 (en) * 2007-08-14 2010-09-07 Chervon Limited Nailer device
US20150079075A1 (en) * 2011-09-15 2015-03-19 Cytodyn Inc. Anti-CD11A Antibodies and Uses Thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4550086A (en) * 1983-02-16 1985-10-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies that recognize human T cells
US4677056A (en) * 1983-08-18 1987-06-30 Sloan-Kettering Institute For Cancer Research Monoclonal antibody subsetting human helper and killer T-cells and method
GB8605316D0 (en) * 1986-03-04 1986-04-09 Royal Free Hosp School Med Immunosuppression
WO1988005592A1 (fr) * 1987-01-24 1988-07-28 Dai Nippon Insatsu Kabushiki Kaisha Support d'enregistrement optique et production de ce support

Also Published As

Publication number Publication date
IE62056B1 (en) 1994-12-14
DE3855201D1 (de) 1996-05-15
JPH03501804A (ja) 1991-04-25
EP0387286A1 (fr) 1990-09-19
EP0387286B1 (fr) 1996-04-10
EP0387286A4 (en) 1990-10-10
CN1033074A (zh) 1989-05-24
AR240175A1 (es) 1990-02-28
IE883062L (en) 1989-05-02
US5002869A (en) 1991-03-26
DE3855201T2 (de) 1996-09-05
IL88160A0 (en) 1989-06-30
AU618563B2 (en) 1992-01-02
ES2017806A6 (es) 1991-03-01
WO1989004175A1 (fr) 1989-05-18
JP3158119B2 (ja) 2001-04-23
AU2611488A (en) 1989-06-01
CA1305928C (fr) 1992-08-04

Similar Documents

Publication Publication Date Title
EP0387286A4 (en) Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes
AU1085488A (en) Monoclonal antibodies to a pan-malarial antigen
ZA884651B (en) Monoclonal antibody specific to hiv antigens
ZA884166B (en) A monoclonal antibody
IL93840A0 (en) Novel monoclonal antibody to novel antigen associated with human tumors
GB2196634B (en) Monoclonal antibodies to hiv and related peptides
EP0312996A3 (en) Anti-human bcdf monoclonal antibody
GB8624899D0 (en) Monoclonal antibodies
EP0208902A3 (en) Monoclonal antibody specific for a pigmentation associated antigen
ZA852426B (en) Monoclonal antibody specific for human basal cell surface antigen
GB8621910D0 (en) Monoclonal antibodies
EP0159025A3 (en) Monoclonal antibody specific to human alpha2-plasmin
AU4407989A (en) Monoclonal antibody specific to a novel mucin-like glycoprotein antigen on human carcinoma cells
EP0401247A4 (en) Monoclonal antibody specific to a novel mucin-like glycoprotein surface antigen on human carcinoma cells
EP0267601A3 (en) Anti-pci monoclonal antibody
GB8715347D0 (en) Monoclonal antibodies
EP0511300A4 (en) Monoclonal antibody specific for non-immunodominant epitope of hiv proteins
GB8616174D0 (en) Monoclonal antibodies
EP0393062A4 (en) Monoclonal antibody that recognizes an epitope of the gamma chain of human t cell surface receptors
GB2207921B (en) Monoclonal antibody to omega-gliadin and hybridoma thereof
GB8610203D0 (en) Monoclonal antibodies
GB8619905D0 (en) Monoclonal antibody
IE851995L (en) Monoclonal antibody to carcinoma antigen
GB8604742D0 (en) Monoclonal antibodies to glycoconjugates
GB2215725B (en) Monoclonal antibodies